77 results on '"Siegel, Don L."'
Search Results
2. Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
3. A Keratinocyte-Tethered Biologic Enables Location-Precise Treatment in Mouse Vitiligo
4. Pathologically stiff erythrocytes impede contraction of blood clots
5. A human monoclonal antibody against the distal carboxyl terminus of ADAMTS‐13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura
6. Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children
7. T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma
8. B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
9. CCR5-edited [CD4.sup.+] T cells augment HIV-specific immunity to enable post-rebound control of HIV replication
10. Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models
11. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome
12. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
13. Generation and validation of canine single chain variable fragment phage display libraries
14. Dog erythrocyte antigen 1: mode of inheritance and initial characterization
15. Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with prmphigus cause pathogenicity
16. Translational applications of antibody phage display
17. Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation.
18. Anaphylactoid-like reactions in a patient with HyperLp(a)lipidemia undergoing LDL apheresis with dextran sulfate adsorption and herbal therapy with the spice turmeric
19. The human immune response to red blood cell antigens as revealed by repertoire cloning
20. Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
21. Phage display-based molecular methods in immunohematology
22. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure
23. Developing phage display tools for use in transfusion medicine
24. On the mechanism of staphylococcal protein A immunomodulation
25. A molecular approach for isolating high-affinity Fab fragments that are useful in blood group serology
26. Inappropriate testing for diarrheal diseases in the hospital
27. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation
28. Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge.
29. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.
30. Proteomic Analysis of Pemphigus Autoantibodies Indicates a Larger, More Diverse, and More Dynamic Repertoire than Determined by B Cell Genetics.
31. Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.
32. CAR-T Cell Therapies From the Transfusion Medicine Perspective.
33. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro.
34. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model.
35. The receptor for advanced glycation end products mediates lung endothelial activation by RBCs.
36. Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant Antibody.
37. Update on the cloning of monoclonal anti-desmoglein antibodies from human pemphigus patients: implications for targeted therapy.
38. Targeting Pemphigus Autoantibodies through their Heavy-Chain Variable Region Genes.
39. Mechanism of Genetic Complementation of Ammonium Transport in Yeast by Human Erythrocyte Rh-associated Glycoprotein.
40. Mechanisms of Action of Therapeutics in Idiopathic Thrombocytopenic Purpura.
41. Chromaffin cell synapsin?
42. Expression and Characterization of Recombinant Anti-Rh(D) Antibodies on Filamentous Phage: A Model System for Isolating Human Red Blood Cell Antibodies by Repertoire Cloning
43. Genetic and Immunological Properties of Phage-Displayed Human Anti-Rh(D) Antibodies: Implications for Rh(D) Epitope Topology
44. Isolation of Pathogenic Monoclonal Anti-Desmoglein 1 Human Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies.
45. Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity.
46. Persistence of Anti-Desmoglein 3 IgG+ B-Cell Clones in Pemphigus Patients over Years.
47. Carbohydrate Sequence of the Prostate Cancer-associated Antigen F77 Assigned by a Mucin O-Glycome Designer Array.
48. Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.
49. Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform
50. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.